Independent correlates of rehospitalisation (all cause and CVD related) overall and in HBI and SM groups separately
| All-cause rehospitalisation OR (95% CI) | CVD-related rehospitalisation OR (95% CI) | |||||
| All | SM | HBI | All | SM | HBI | |
| Sociodemographic profile | ||||||
| Age (years) | – | 1.07 (1.02 to 1.34)* | – | – | – | – |
| Sex (female/male) | – | – | – | – | 2.10 (0.95 to 4.61) | – |
| Risk factor profile | ||||||
| Mild cognitive impairment | 3.16 (1.46 to 6.84)* | – | 3.30 (1.25 to 8.69)* | 1.60 (0.94 to 2.74) | – | 2.35 (1.12 to 4.91)* |
| Current smoker† | 0.39 (0.15 to 0.99)* | 0.15 (0.03 to 0.66)* | – | – | – | – |
| Comorbidity profile | ||||||
| Type 2 diabetes | 0.36 (0.15 to 0.83)* | 0.18 (0.04 to 0.79)* | – | – | – | – |
| Treatment profile | ||||||
| Calcium channel blocker | – | – | – | – | 2.57 (0.87 to 7.63) | – |
| Angiotensin II receptor blocker | 2.50 (0.89 to 7.04) | 8.82 (0.84 to 92.54) | – | – | – | – |
| Digoxin | – | – | – | 1.84 (1.05 to 3.24)* | 2.58 (1.08 to 6.16)* | – |
*P<0.05.
**P<0.001.
†Assessed in n=258 patients.
CVD, cardiovascular disease; HBI, home based intervention; SM, standard management.